Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus: New Diagnostic Criteria of Fulminant Type 1 Diabetes Mellitus (2012)
详细信息    查看全文
  • 作者：Akihisa Imagawa (1)
    Toshiaki Hanafusa (2)
    Takuya Awata (3)
    Hiroshi Ikegami (4)
    Yasuko Uchigata (5)
    Haruhiko Osawa (6)
    Eiji Kawasaki (7)
    Yumiko Kawabata (4)
    Tetsuro Kobayashi (8)
    Akira Shimada (9)
    Ikki Shimizu (10)
    Kazuma Takahashi (11)
    Masao Nagata (12)
    Hideichi Makino (13)
    Taro Maruyama (14)
  • 关键词：Fulminant ; Criteria ; Diagnosis
  • 刊名：Diabetology International
  • 出版年：2012
  • 出版时间：December 2012
  • 年：2012
  • 卷：3
  • 期：4
  • 页码：179-183
  • 全文大小：219KB
  • 参考文献：1. Imagawa A, Hanafusa T, Awata T, Ikegami H, Uchigata Y, Osawa H, Kawasaki E, Kawabata Y, Kobayashi T, Shimada A, Shimizu I, Takahashi K, Nagata M, Makino H, Maruyama T. Report of the Committee of Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus: New Diagnostic Criteria of Fulminant Type 1 Diabetes Mellitus. J Japan Diab Soc. 2012;55:815-0 (Japanese).
    2. Imagawa A, Hanafusa T, Miyagawa J, Osaka IDDM Study Group. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. N Engl J Med. 2000;342:301-. CrossRef
    3. Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Toyoda T, Maruyama T, Makino H. Fulminant type 1 diabetes: a nationwide survey in Japan. Diabetes Care. 2003;26:2345-2. CrossRef
    4. Hanafusa T, Imagawa A, Iwahashi H, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Maruyama T, Makino H. Report of Japan Diabetes Society Committee on fulminant type 1 diabetes mellitus research: epidemiological and clinical analysis and proposal of diagnostic criteria. J Japan Diab Soc. 2005;48(suppl1):A1-3. (Japanese).
    5. Imagawa A, Hanafusa T, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Maruyama T, Makino H. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia. 2005;48:294-00. Erratum in: Diabetologia. 2008;51:524-.
    6. Shimizu I, Makino H, Hanafusa T, Imagawa A, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Maruyama T. Immunogenetic characteristics of fulminant type 1 diabetes mellitus associated with pregnancy: a nationwide survey. J Japan Diab Soc. 2005;48(suppl1):A15-. (Japanese).
    7. Shimizu I, Makino H, Imagawa A, Iwahashi H, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Maruyama T, Hanafusa T. Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy. J Clin Endocrinol Metab. 2006;91:471-. CrossRef
    8. Shimizu I, Makino H, Imagawa A, Iwahashi H, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Maruyama T, Hanafusa T. Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy: report of the Japan Diabetes Society Committee on Fulminant Type 1 Diabetes Mellitus Research. J Japan Diab Soc. 2006;49:755-0. (Japanese).
    9. Kawasaki E, Shimizu I, Hanafusa T, Imagawa A, Iwahashi H, Uchigata Y, Kanatsuka A, Kobayashi T, Shimada A, Maruyama T, Makino H. Nationwide survey on the prevalence of type 1 diabetes associated with pregnancy. Diabetes Pregnancy. 2006;6:104-. (Japanese).
    10. Hanafusa T, Imagawa A, Iwahashi H, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Maruyama T, Makino H, Murase Y, Ikegami H. Report of the committee of the Japan Diabetes Society on research on fulminant type 1 diabetes mellitus: analysis of HLA serotype and diabetic microangiopathy. J Japan Diab Soc. 2007;50:825-3. (Japanese).
    11. Hanafusa T, Imagawa A, Iwahashi H, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Maruyama T, Makino H. Report of the Japan Diabetes Society’s Committee on fulminant type 1 diabetes mellitus: analysis of antiviral antibodies at disease onset. J Japan Diab Soc. 2008;51:531-. (Japanese).
    12. Imagawa A, Hanafusa T, Iwahashi H, Uchigata Y, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Maruyama T, Makino H. Uniformity in clinical and HLA-DR status regardless of age and gender within fulminant type 1 diabetes. Diabetes Res Clin Pract. 2008;82:233-. CrossRef
    13. Takaike H, Uchigata Y, Iwamoto Y, Imagawa A, Iwahashi H, Kanatsuka A, Kawasaki E, Kobayashi T, Shimada A, Shimizu I, Hanafusa T, Maruyama T, Makino H. Nationwide survey to compare the prevalence of transient elevation of liver transaminase during treatment of diabetic ketosis or ketoacidosis in new-onset acute and fulminant type 1 diabetes mellitus. Ann Med. 2008;40:395-00. CrossRef
    14. Kawabata Y, Ikegami H, Awata T, Imagawa A, Maruyama T, Kawasaki E, Tanaka S, Shimada A, Osawa H, Kobayashi T, Hanafusa T, Tokunaga K, The Committee on Type 1 Diabetes, Japan Diabetes Society. Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset. Diabetologia. 2009;52:2513-1. CrossRef
    15. Koga M, Murai J, Saito H, Kasayama S, Imagawa A, Hanafusa T. Japan Diabetes Society’s Committee on Research on Type 1 Diabetes. Serum glycated albumin to haemoglobin A(1C) ratio can distinguish fulminant type 1 diabetes mellitus from type 2 diabetes mellitus. Ann Clin Biochem. 2010;47:313-. CrossRef
    16. Nakamura K, Kawasaki E, Imagawa A, Awata T, Ikegami H, Uchigata Y, Kobayashi T, Shimada A, Nakanishi K, Makino H, Maruyama T, The Research Committee on Type 1 Diabetes of the Japan Diabetes Society. Type 1 diabetes and interferon therapy: a nationwide survey in Japan. Diabetes Care. 2011;34:2084-. CrossRef
    17. Tsutsumi C, Imagawa A, Ikegami H, Makino H, Kobayashi T, Hanafusa T, The Japan Diabetes Society Committee on Type 1 Diabetes Mellitus Research. Class II HLA genotype in fulminant type 1 diabetes –a nationwide survey with reference to glutamic acid decarboxylase antibodies. J Diabetes Invest. 2012;3:62-. CrossRef
    18. Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Diabetol Int. 2012;3:8-0. CrossRef
    19. Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest. 2012;3:39-0. CrossRef
    20. Hirata H, Shimada A, Imagawa A, Awata T, Ikegami H, Uchigata Y, Osawa H, Kawasaki E, Kawabata Y, Kobayashi T, Shimizu I, Takahashi K, Nagata M, Makino H, Maruyama T, Hanafusa T, Committee on Type 1 diabetes. Clinical characteristics of cases that progress rapidly from type 2 diabetes to insulin deficiency like fulminant type 1 diabetes: subcommittee report on fulminant and acute type 1 diabetes, Committee on type 1 diabetes, Japan Diabetes Society. J Japan Diab Soc. 2012;55:505-1. (Japanese).
  • 作者单位：Akihisa Imagawa (1)
    Toshiaki Hanafusa (2)
    Takuya Awata (3)
    Hiroshi Ikegami (4)
    Yasuko Uchigata (5)
    Haruhiko Osawa (6)
    Eiji Kawasaki (7)
    Yumiko Kawabata (4)
    Tetsuro Kobayashi (8)
    Akira Shimada (9)
    Ikki Shimizu (10)
    Kazuma Takahashi (11)
    Masao Nagata (12)
    Hideichi Makino (13)
    Taro Maruyama (14)

    1. Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Suita, Japan
    2. Department of Internal Medicine (I), Osaka Medical College, Takatsuki, Japan
    3. Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan
    4. Department of Endocrinology, Metabolism and Diabetes, Kinki University School of Medicine, Osaka, Japan
    5. Diabetes Center, Tokyo Women’s Medical University School of Medicine, Tokyo, Japan
    6. Department of Laboratory Medicine, Ehime University School of Medicine, Ehime, Japan
    7. Department of Metabolism/Diabetes and Clinical Nutrition, Nagasaki University Hospital, Nagasaki, Japan
    8. Third Department of Internal Medicine, University of Yamanashi School of Medicine, Yamanashi, Japan
    9. Department of Internal Medicine, Saiseikai Central Hospital, Tokyo, Japan
    10. Department of Internal Medicine, The Sakakibara Heart Institute of Okayama, Okayama, Japan
    11. Department of Diabetes and Metabolism, Iwate Medical University, Morioka, Japan
    12. Department of Internal Medicine, Kakogawa Municipal Hospital, Kakogawa, Japan
    13. Diabetes Center, Shiraishi Hospital, Ehime, Japan
    14. Department of Internal Medicine, Saitama Social Insurance Hospital, Saitama, Japan
文摘
We have revised a part of the diagnostic criteria for fulminant type 1 diabetes. The new criteria were set both to express the essence of this disease of rapid increase of patients-blood glucose and to be highly sensitive to reduce the misdiagnosis. After analyzing the data of 382 patients with newly-diagnosed fulminant type 1 diabetes, we adopted the HbA1c level of 8.7?% (NGSP value). The new criterion indicates 100?% of sensitivity and best value by ROC (receiver operation curve) analysis. In addition, we added a comment that “This value (HbA1c?<?8.7?% in NGSP) is not applicable for patients with previously diagnosed glucose intolerance-on the new criteria and also a comment that “Association with HLA DRB1*04:05-DQB1*04:01 is reported-as a related finding. We did not revise the screening criteria and the other part of the diagnostic criteria, because they are still reliable.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址：北京市海淀区学院路29号 邮编：100083

电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700